Stocks and Investing Stocks and Investing
Wed, December 14, 2022

Paul Choi Initiated (XENE) at Strong Buy and Held Target at $60 on, Dec 14th, 2022


Published on 2024-10-28 00:34:20 - WOPRAI, Paul Choi
  Print publication without navigation


Paul Choi of Goldman Sachs, Initiated "Xenon Pharmaceuticals Inc." (XENE) at Strong Buy and Held Target at $60 on, Dec 14th, 2022.

Paul has made no other calls on XENE in the last 4 months.



There are 6 other peers that have a rating on XENE. Out of the 6 peers that are also analyzing XENE, 0 agree with Paul's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Paul


  • Joseph Thome of "Cowen & Co." Initiated at Buy on, Monday, December 12th, 2022
  • Mohit Bansal of "Wells Fargo" Initiated at Buy and Held Target at $50 on, Monday, November 28th, 2022
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Decreased Target to $49 on, Friday, November 11th, 2022
  • Danielle Brill of "Raymond James" Initiated at Buy and Held Target at $52 on, Wednesday, October 19th, 2022
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $49 on, Tuesday, October 11th, 2022
  • Jason Gerberry of "B of A Securities" Initiated at Strong Buy on, Monday, August 29th, 2022

Contributing Sources